USANA Health Sciences, Inc. (NYSE:USNA) announced its quarterly earnings results on Tuesday. The company reported $0.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.06 by $0.08, Bloomberg Earnings reports. The firm had revenue of $257.10 million during the quarter, compared to the consensus estimate of $273.61 million. USANA Health Sciences had a return on equity of 31.84% and a net margin of 9.71%. The firm’s revenue was down .5% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.07 EPS. USANA Health Sciences updated its FY17 guidance to $3.50-3.70 EPS.

Shares of USANA Health Sciences (USNA) traded up 1.49% during mid-day trading on Tuesday, hitting $64.75. The stock had a trading volume of 117,399 shares. USANA Health Sciences has a 52-week low of $52.55 and a 52-week high of $75.00. The stock’s 50-day moving average price is $64.22 and its 200-day moving average price is $60.96. The firm has a market cap of $1.59 billion, a PE ratio of 16.35 and a beta of 1.13.

USNA has been the subject of several analyst reports. Zacks Investment Research raised USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Wednesday, April 12th. Pivotal Research reissued a “hold” rating and issued a $55.00 price objective (down from $75.00) on shares of USANA Health Sciences in a research note on Monday, May 1st. Finally, BidaskClub raised USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Tuesday, June 13th.

In other news, Director Gilbert A. Fuller sold 4,884 shares of the business’s stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $64.38, for a total value of $314,431.92. Following the sale, the director now directly owns 4,884 shares of the company’s stock, valued at approximately $314,431.92. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Myron W. Wentz sold 40,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 5th. The stock was sold at an average price of $64.15, for a total value of $2,566,000.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 134,735 shares of company stock worth $8,371,021. Insiders own 53.20% of the company’s stock.

WARNING: This piece of content was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of US and international copyright law. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/07/25/usana-health-sciences-inc-nyseusna-issues-quarterly-earnings-results.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Earnings History for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.